With the game-changing HIV prevention treatment pre-exposure prophylaxis (PrEP) reportedly set to get the tick of approval from PBAC, the Turnbull Government must commit to making the medicine available to those who need it as soon as possible.

Reports indicate that the Pharmaceutical Benefits Advisory Committee (PBAC) will today confirm a positive recommendation for PrEP to be listed on the Pharmaceutical Benefits Scheme.

This is extremely encouraging news and would be a massive step forward towards ending new HIV transmissions in Australia.

More than 1,000 Australians are still diagnosed with HIV every year, and in some areas we are going backwards. Shockingly, the rate of new infections in Aboriginal and Torres Strait Islanders communities is now above the Australian average for the first time ever.